Low-intensity repetitive transcranial magnetic stimulation is safe and well tolerated by people living with MS - outcomes of the phase I randomised controlled trial (TAURUS).

Phuong Tram Nguyen Amin Zarghami Kalina Makowiecki Natasha StevensChigozie EzegbeKain KyleChenyu WangLinda LyKatie De La RueMark R HinderLewis JohnsonJennifer RodgerSamantha CooperCarlie L Cullen Michael Harry Barnett Kaylene M YoungBruce V Taylor

Published in: Multiple sclerosis journal - experimental, translational and clinical (2024)

Twenty sessions of rTMS is safe and well tolerated in a small group of people with MS. The study protocol and procedures are feasible. Improvement of sham is warranted before further investigating safety and efficacy.

Keyphrases

transcranial magnetic stimulation
high frequency
study protocol
mass spectrometry
multiple sclerosis
ms ms
randomized controlled trial
double blind
clinical trial
open label
type diabetes
placebo controlled
glycemic control